Skip to content
Search

Latest Stories

MHRA issues recall notice for Oxylan 40mg tablets  

pharmacy.biz Staff
By pharmacy.biz StaffSep 03, 2020
pharmacy.biz Staff
See Full Bio

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Oxylan 40mg prolonged-release tablets of GL Pharma.

GL Pharma is recalling the below batch of the tablets due to out of specification results for dissolution obtained during routine stability testing.

Product Details

Oxylan 40mg prolonged-release tablets, PL 21597/0064

Active pharmaceutical ingredient: Oxycodone Hydrochloride

Batch NumberExpiry DatePack SizeFirst Distributed
9F119A31/05/20245602/06/2020

The healthcare professionals have been adviced to stop supplying the batch immediately and remove it from the shelves within the pharmacy.

It has also been suggested to quarantine all remaining stock and return it to the supplier using approved process.

Related News

GP surgery upgrades for annual appointments
News

GP surgery upgrades to create 8.3 million more annual appointments

Empowering women in pharmacy through self-advocacy
Guest Blog

Advocate for yourself – Celebrating International Women’s Day

NHS England Abolition: Wes Streeting outlines progress
News

Wes Streeting provides update on NHS England Abolition

It is official: Opella is now a standalone company
News

Opella becomes standalone company as Sanofi-CD&R deal closes

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
PHOENIX expands operations with new depot in Aberdeen

Representational image

Photo credit: PHOENIX

PHOENIX opens new depot in Aberdeen

PHOENIX has announced the opening of a new depot in Aberdeen to support its growing customer base in Scotland.

The pharmaceutical wholesaler already operates 13 depots across the UK, collectively delivering over 250 million packs of medicines each year.

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Pharmacist declining participation in assisted dying under new UK legislation

It could take another four years for assisted dying to become law

Pic credit: iStock

Pharmacists to have choice to opt-out of assisted dying process

Pharmacists will not be forced to be a part in assisted dying cases with the MP leading the campaign expected to made amendments to the bill which is currently going through parliamentary process.

Kim Leadbeater, the MP behind the Terminally Ill Adults (End of Life) Bill, will say that “no person is under any duty to participate in the provision of assistance”.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc